The purpose of this exhibit is explore pitfalls in our experience with SPECT-CT Iodine-123 (I-123) MIBG imaging in patients with neuroblastoma. SPECT-CT can more specifically localize areas of uptake over planar imaging and mitigate false-positive results with correlative anatomic information. We will review cases of false-positive MIBG uptake in nonmalignant sites, cases of false-negative MIBG uptake in neuroblastoma/neural crest tumors, and cases of secondary tumors/malignancies occurring in the setting of known neuroblastoma, with variable uptake on MIBG.
Read More
Meeting name:
SPR 2019 Annual Meeting & Postgraduate Course
, 2019
Authors:
Lai Lillian,
Berkovich Rachel,
Goodarzian Fariba
Keywords:
MIBG,
neuroblastoma,
SPECT-CT